Breaking News
Sort by:
Top Post
Viome Life Sciences Unveils CancerDetect™, the Future of Oral and Throat Cancer Detection
Viome Life Sciences, a mission-driven biotechnology company, announces the arrival of its CancerDetect™ test for oral […]
HealthTech: Healing Health Care’s Ailments
By Frédérique Carrier, Head of Investment Strategy, RBC Wealth Management With bloated costs and gaps […]
£36 Million Boost for AI Technologies to Revolutionise NHS Care
New technology will help detect cancers and provide mental health support Projects are part of […]
Qure.ai ’s Brain CT AI Wins Funding from the NHS
The UK Department of Health and Social Care announced that Qure.ai has been selected as […]
Ibex Receives CE Mark for AI Breast Cancer Solution
Ibex Medical Analytics, an AI-powered cancer diagnostics firm, has received the CE mark for the […]
Drug Discovery Gets Jolt of AI via NVIDIA Collaborations with AstraZeneca, U of Florida Health
NVIDIA is collaborating with biopharmaceutical company AstraZeneca and the University of Florida’s academic health center, […]
Babylon: Meet the Largest Digital-First, Value-Based Care Provider in the United States
Babylon today announced that its recent strategic partnerships and acquisitions — combined with significant organic […]
AI Consultation System PATCHS Could Slash GP Waiting Times
An AI online consultation system PATCHS could slash GP waiting times from three weeks to […]
AI Powered Eye-Test a ‘Healthcare Game-changer’
In an Australian first, Bupa Optical customers can access innovative Artificial Intelligence (AI) enabled eye […]
Welsh Startup Antiverse Raises $2m for Antibody Discovery Toolkit
New biotech Antiverse has raised seed funding of £1.4 million ($2 million) to develop its […]
NHSX: AI at the Forefront of Efforts to Treat Coronavirus Patients
NHSX, a unit tasked with driving the digital transformation of care in the NHS, has […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more